Background As there are limited data of the immunogenicity of the Sinopharm/BBIBP-CorV
in different populations, antibody responses against different SARS-CoV-2 variants of …

As there are limited data of the immunogenicity of the Sinopharm/BBIBP‐CorV in different
populations, antibody responses against different SARS‐CoV‐2 variants of concern and T cell …

Due to limited access to vaccines, many countries have only administered a single dose of
the AZD1222, whereas the dosage intervals have increased≥ 4 wk. We sought to investigate …

Background As there are limited data of the immunogenicity of the Sinopharm/BBIBP-CorV
in different populations, antibody responses against different SARS-CoV-2 variants of …

Thirty-eight negative kinase-1 (TNK1) is an understudied nonreceptor tyrosine kinase with no
established function or mechanism of regulation. We identified TNK1 as the primary kinase …

Background Individuals who have not been exposed to the SARS-CoV2 virus have been
shown to have T cells that respond to the virus, possibly due to the presence of cross-reactive T …

We recently developed a machine learning (ML) based program to predict cancer hotspots.
Here, we applied the ML program to 32 non‐receptor tyrosine kinases (NRTKs) and …

Since identification of the first Sri Lankan individual with the SARS-CoV-2 in early March
2020, small clusters that occurred were largely contained until the current extensive outbreak …

Background To determine the kinetics and persistence of immune responses following the
Sinopharm/BBIBP-CorV, we investigated immune responses in a cohort of Sri Lankan …